The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Proactive assessment of patient reported outcomes in patients with ovarian cancer.
 
Ainhoa Madariaga
Honoraria - AstraZeneca; Clovis Oncology; GlaxoSmithKline
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline; PharmaMar
Research Funding - Kyowa Kirin International
 
Rodrigo Sanchez-Bayona
Honoraria - AstraZeneca; GlaxoSmithKline; Lilly; Novartis; Seagen
Consulting or Advisory Role - GlaxoSmithKline; Lilly; Novartis
Speakers' Bureau - AstraZeneca; Novartis
Expert Testimony - AstraZeneca; Novartis
Travel, Accommodations, Expenses - AstraZeneca; Pfizer
 
Lawrence Kasherman
No Relationships to Disclose
 
Jose Manuel Estrada-Lorenzo
No Relationships to Disclose
 
Stephanie Lheureux
Honoraria - AstraZeneca; GlaxoSmithKline; Merck; Roche/Genentech; Shattuck Labs
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline; Merck; Novartis; Roche/Genentech; Shattuck Labs
Research Funding - AstraZeneca (Inst); GlaxoSmithKline (Inst); Merck (Inst); Regeneron (Inst); Repare Therapeutics (Inst); Roche/Genentech (Inst); Tesaro (Inst)
 
Luis Manso
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Eisai; GlaxoSmithKline; Lilly; Novartis; Pfizer; Pierre Fabre; Roche/Genentech; Tesaro
Speakers' Bureau - AstraZeneca; Lilly; Novartis; Pfizer; Roche/Genentech
Research Funding - Tesaro
Travel, Accommodations, Expenses - GlaxoSmithKline; MSD Oncology; Novartis; Roche/Genentech; Tesaro
 
Pablo Tolosa Ortega
Consulting or Advisory Role - Adamed; AstraZeneca; Daiichi Sankyo; Novartis; Seagen
Speakers' Bureau - AstraZeneca; Daiichi-Sankyo; Lilly; Novartis; Pfizer; Seagen
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline; Pfizer
 
Manuel Alva Bianchi
Honoraria - Novartis
Travel, Accommodations, Expenses - Novartis
 
Laura Lema
No Relationships to Disclose
 
Eva M Ciruelos
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Lilly; MSD Oncology; Novartis; Novartis; Pfizer; Roche; Seagen
Speakers' Bureau - Daiichi Sankyo/Astra Zeneca; Lilly; Novartis; Roche
Travel, Accommodations, Expenses - Pfizer; Roche
 
David Valcarcel
Consulting or Advisory Role - Amgen; BMS; Celgene; GlaxoSmithKline; Jazz Pharmaceuticals; NOVARTIS; Pfizer; Sanofi; SOBI; Takeda
Speakers' Bureau - Amgen; Astellas Pharma; Astellas Pharma; BMS; Celgene; Gebro Pharma; GlaxoSmithKline; Jazz Pharmaceuticals; Kite, a Gilead company; Novartis; Pfizer; Sanofi/Aventis
Travel, Accommodations, Expenses - Amgen; Celgene; GlaxoSmithKline; Jazz Pharmaceuticals; Pfizer
 
Ana Oaknin
Consulting or Advisory Role - AGENUS; AstraZeneca; Clovis Oncology; Corcept Therapeutics; Deciphera; Eisai; EMD Serono; Genmab; GlaxoSmithKline; Immunogen; ITeos Therapeutics; Merck Sharp & Dohme; Mersana; Novocure; PharmaMar; prIME Oncology; Roche; Roche; Seagen; Shattuck Labs; Sutro Biopharma; Tesaro
Research Funding - Abbvie (Inst); Advaxis (Inst); Aeterna Zentaris (Inst); Amgen (Inst); Aprea Therapeutics (Inst); Bristol-Myers Squibb International Corporation (BMS) (Inst); Clovis Oncology (Inst); Eisai (Inst); Immunogen (Inst); Medimmune (Inst); Merck Sharp & Dohme (Inst); Millennium (Inst); PharmaMar (Inst); Regeneron (Inst); Roche (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; PharmaMar; Roche
 
Amit M. Oza
(OPTIONAL) Uncompensated Relationships - Ozmosis Research